Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$5.75M Buy
94,072
+5,004
+6% +$303K 1.35% 23
2017
Q2
$5.45M Sell
89,068
-1,119
-1% -$68.1K 1.3% 26
2017
Q1
$5.47M Sell
90,187
-3,141
-3% -$191K 1.3% 24
2016
Q4
$5.24M Sell
93,328
-1,663
-2% -$97.3K 1.3% 24
2016
Q3
$5.66M Sell
94,991
-1,557
-2% -$91K 1.4% 21
2016
Q2
$5.31M Buy
96,548
+288
+0.3% +$15.3K 1.31% 23
2016
Q1
$4.86M Sell
96,260
-810
-0.8% -$39.7K 1.24% 24
2015
Q4
$4.89M Buy
97,070
+2,076
+2% +$105K 1.22% 26
2015
Q3
$4.48M Sell
94,994
-623
-0.7% -$33.1K 1.16% 28
2015
Q2
$5.19M Sell
95,617
-1,363
-1% -$76.4K 1.2% 23
2015
Q1
$5.32M Buy
96,980
+1,127
+1% +$63.8K 1.21% 25
2014
Q4
$5.19M Buy
95,853
+5,113
+6% +$285K 1.2% 26
2014
Q3
$5.13M Buy
90,740
+431
+0.5% +$24.2K 1.25% 25
2014
Q2
$4.99M Buy
90,309
+1,527
+2% +$83.3K 1.2% 28
2014
Q1
$4.81M Sell
88,782
-262
-0.3% -$13.6K 1.2% 30
2013
Q4
$4.25M Sell
89,044
-661
-0.7% -$30.2K 1.08% 34
2013
Q3
$4.08M Buy
89,705
+294
+0.3% +$13.4K 1.15% 31
2013
Q2
$3.96M Buy
+89,411
New +$3.99M 1.18% 30

Other funds holding MRK

Davidson & Garrard's MRK Position: Q3 2017 in Review

Davidson & Garrard increased its Merck (MRK) stake by 5.6% in Q3 2017, buying an estimated $303K and bringing the position to 94,072 shares worth $5.75M. The position accounts for 1.35% of the portfolio, ranked #23.

Davidson & Garrard first reported a position in MRK in Q2 2013 and has held it in 18 quarters since. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • Davidson & Garrard held 94,072 shares of Merck worth $5.75M as of Q3 2017.
  • Davidson & Garrard bought 5,004 Merck shares in Q3 2017, an estimated $303K.
  • Merck made up 1.35% of Davidson & Garrard's portfolio in Q3 2017, its #23 holding.
  • Davidson & Garrard first reported a position in Merck in Q2 2013 and has held it in 18 quarters since.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on Davidson & Garrard's 13F filing for Q3 2017, filed 7 Nov 2017.